Florida’s Life Science Leaders United To Celebrate 25 Years of Innovation and Growth in the State
BioFlorida's 25th Annual Conference united statewide leaders of Florida's life sciences industry representing biopharmaceutical, medical technology, and digital health companies, globally recognized research universities and research institutions, and the state's health systems to spotlight the continued momentum and success in science, business, and public policy and spur collaboration and future growth.
Concept Companies and Lacerta Therapeutics Form a Strategic Partnership Around Facilities Expansion and Financing
Concept Companies, a national commercial real estate developer with a specialty across multiple asset classes including science and technology, and Lacerta Therapeutics, Inc., a leader in the AAV gene therapy space, today announced a strategic collaboration providing Lacerta with access to financing to support expansion of operations and new facilities. The financing is being provided via Agility Venture Capital, the funding arm of Concept Companies.
Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua’s Progress District
Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company. The site will be located adjacent to Lacerta Therapeutics' current location in Alachua, Florida, in Copeland Park, which Lacerta has occupied since 2020.
Lacerta Therapeutics Expands Executive Leadership Team
UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.
Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff to Its Board of Directors
UF startup and UF Innovate | Accelerate at Sid Martin Biotech graduate Lacerta Therapeutics, Inc., a gene therapy company dedicated to the discovery and development of AAV-based gene therapies, appoints Min Wang, PhD, JD and Marc Wolff to its Board of Directors.
Pandemic a Boon for Area’s Biotech Industry
While industries like airlines, hospitality and retail struggled much of 2020, one local sector took off during the COVID-19 pandemic. Alachua’s biotechnology... Read More
Lacerta Therapeutics Signs Gene Therapy Research Partnership With UCB
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced a new gene therapy... Read More
Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar... Read More
Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua’s Copeland Park
Gainesville-based developer Concept Companies has completed construction on a new 12,950-square-foot office and lab building in Copeland Park for UF startup and... Read More
New Location for Lacerta Therapeutics in Alachua’s Copeland Park
UF startup and UF Innovate | Sid Martin Biotech resident client Lacerta Therapeutics, a clinical-stage gene therapy company, has announced the commencement... Read More
